Cohort Study | Biomarker trends, incidence, and outcomes of immune checkpoint inhibitor–induced myocarditis

Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor–Induced Myocarditis – JACC: CardioOncology

Editorial: Biomarkers for Immune Checkpoint Inhibitor–Induced Myocarditis: Caution Needed – JACC: CardioOncology

News Release: New biomarker strategy devised to screen for, diagnose deadly heart complication from cancer treatment – University of Michigan

Commentary: Biomarker Trends of Immune Checkpoint Inhibitor–Induced Myocarditis – American College of Cardiology

Commentary from the author on Twitter

Our work is now published in @JACCJournals!

ICI #myocarditis rarely occurs in isolation. Elevations in routinely measured biomarkers should prompt further testing for cardiac injury? @salimhayek @umichCVC @UMRogelCancer

Check it out?https://t.co/6o8k4Pbp8J pic.twitter.com/cJzgpqPkL0

— Alexi Vasbinder, PhD, RN (@Avasbind) December 20, 2022